Bharat Biotech has commenced direct supply of its C-19 vaccine ‘COVAXIN’ to 14 states, including Delhi and Maharashtra, with effect from May 1, according to the company’s Joint Managing Director Suchitra Ella.
The firm has started supplying its C-19 vaccine to the states based on the allocations received by the central government.
To read more about Covaxin, click here
“Bharat Biotech confirms direct supplies of COVAXIN to the following state govt’s since 1/5/21, based on the allocations received by GoI. Requests have been received from other states, & will be processed for distribution based on availability of stocks 24×7,” Ella tweeted.
The company is supplying vaccines to Andhra Pradesh, Assam, Chhattisgarh, Gujarat, Jammu & Kashmir, Jharkhand, Madhya Pradesh, Odisha, Tamil Nadu, Telangana, Uttar Pradesh and West Bengal.
On April 29, Bharat Biotech announced a cut in the price of ‘COVAXIN’ for states to ₹400 per dose from the earlier ₹600 per dose.
This followed widespread criticism of its pricing policy as it sold COVAXIN to the central government at ₹150 per dose.
Subscribe for daily free updates on Telegram
For daily free updates on WhatsApp, click here